Joerg Koglin

8.7k total citations · 3 hit papers
47 papers, 5.6k citations indexed

About

Joerg Koglin is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Joerg Koglin has authored 47 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 23 papers in Cardiology and Cardiovascular Medicine and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joerg Koglin's work include Coronary Interventions and Diagnostics (19 papers), Cerebrovascular and Carotid Artery Diseases (13 papers) and Cardiac Imaging and Diagnostics (11 papers). Joerg Koglin is often cited by papers focused on Coronary Interventions and Diagnostics (19 papers), Cerebrovascular and Carotid Artery Diseases (13 papers) and Cardiac Imaging and Diagnostics (11 papers). Joerg Koglin collaborates with scholars based in United States, Germany and Netherlands. Joerg Koglin's co-authors include Mary E. Russell, Paul W. Armstrong, Eric D. Peterson, Darren K. McGuire, Rury R. Holman, Eberhard Standl, Jennifer B. Green, Frans Van de Werf, Michael Pencina and M. Angelyn Bethel and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Joerg Koglin

45 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

2015 1.9k citations Jennifer B. Green, M. Angelyn Bethel et al. New England Journal of Medicine profile →
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

2020 781 citations Paul W. Armstrong, Burkert Pieske et al. New England Journal of Medicine profile →
Comparison of a Polymer-Based Paclitaxel-Eluting Stent With a Bare Metal Stent in Patients With Complex Coronary Artery Disease

2005 612 citations Gregg W. Stone, Stephen G. Ellis et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joerg Koglin United States	25	2.8k	2.5k	2.2k	996	821	47	5.6k
Matthew A. Cavender United States	28	2.3k 0.8×	2.1k 0.8×	4.7k 2.2×	2.0k 2.0×	370 0.5×	86	6.7k
Michelle L. O’Donoghue United States	43	4.2k 1.5×	3.4k 1.3×	953 0.4×	488 0.5×	381 0.5×	116	6.9k
İlke Sipahi United States	26	2.2k 0.8×	3.0k 1.2×	1.1k 0.5×	380 0.4×	789 1.0×	62	5.0k
Toru Miyoshi Japan	37	2.2k 0.8×	1.2k 0.5×	718 0.3×	895 0.9×	464 0.6×	233	4.4k
Prediman K. Shah United States	25	2.8k 1.0×	3.5k 1.4×	1.1k 0.5×	483 0.5×	890 1.1×	56	6.0k
Nicolas von Beckerath Germany	35	4.5k 1.6×	2.9k 1.1×	611 0.3×	358 0.4×	591 0.7×	78	6.0k
Steffen Helqvist Denmark	37	2.8k 1.0×	3.1k 1.2×	873 0.4×	636 0.6×	447 0.5×	126	5.4k
Christian Besler Germany	35	2.4k 0.8×	1.1k 0.4×	678 0.3×	1.0k 1.0×	423 0.5×	92	4.4k
Hirofumi Soejima Japan	35	2.0k 0.7×	948 0.4×	631 0.3×	652 0.7×	394 0.5×	126	3.9k
Hideo Izawa Japan	33	2.0k 0.7×	1.0k 0.4×	568 0.3×	933 0.9×	370 0.5×	183	4.0k

Countries citing papers authored by Joerg Koglin

Since Specialization

Citations

This map shows the geographic impact of Joerg Koglin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joerg Koglin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joerg Koglin more than expected).

Fields of papers citing papers by Joerg Koglin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joerg Koglin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joerg Koglin. The network helps show where Joerg Koglin may publish in the future.

Co-authorship network of co-authors of Joerg Koglin

This figure shows the co-authorship network connecting the top 25 collaborators of Joerg Koglin. A scholar is included among the top collaborators of Joerg Koglin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joerg Koglin. Joerg Koglin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Greene, Stephen J., Justin A. Ezekowitz, Kevin J. Anstrom, et al.. (2022). Medical Therapy During Hospitalization for Heart Failure With Reduced Ejection Fraction: The VICTORIA Registry. Journal of Cardiac Failure. 28(7). 1063–1077. 33 indexed citations

deFilippi, Christopher R., Wendimagegn Alemayehu, Adriaan A. Voors, et al.. (2021). BASELINE CARDIAC TROPONIN T, CLINICAL OUTCOMES AND VERICIGUAT TREATMENT EFFECT IN HEART FAILURE WITH REDUCED EJECTION FRACTION STUDY: INSIGHTS FROM THE VICTORIA TRIAL. Journal of the American College of Cardiology. 77(18). 565–565. 1 indexed citations

Voors, Adriaan A., Hillary Mulder, Eugene B. Reyes, et al.. (2021). Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA ( Vericiguat Global Study in Subjects with HFrEF ) trial. European Journal of Heart Failure. 23(8). 1313–1321. 66 indexed citations

Pieske, Burkert, Mahesh J. Patel, Cynthia M. Westerhout, et al.. (2019). Baseline Features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) Trial. European Journal of Heart Failure. 21(12). 1596–1604. 62 indexed citations

Armstrong, Paul W., Lothar Roessig, Mahesh J. Patel, et al.. (2017). A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator. JACC Heart Failure. 6(2). 96–104. 145 indexed citations

Green, Jennifer B., M. Angelyn Bethel, Paul W. Armstrong, et al.. (2015). Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. New England Journal of Medicine. 373(3). 232–242. 1866 indexed citations breakdown →

Geiger, Mary Jane, Cyrus R. Mehta, J. Rick Turner, et al.. (2014). Clinical Development Approaches and Statistical Methodologies to Prospectively Assess the Cardiovascular Risk of New Antidiabetic Therapies for Type 2 Diabetes. Therapeutic Innovation & Regulatory Science. 49(1). 50–64. 14 indexed citations

Newman, Mark F., T. Bruce Ferguson, Jennifer A. White, et al.. (2012). Effect of Adenosine-Regulating Agent Acadesine on Morbidity and Mortality Associated With Coronary Artery Bypass Grafting. JAMA. 308(2). 157–64. 34 indexed citations

Ellis, Stephen G., Charles O’Shaughnessy, Sandra L. Martin, et al.. (2008). Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial. European Heart Journal. 29(13). 1625–1634. 41 indexed citations

10.

Tsuchida, Keiichi, Patrick W. Serruys, Nico Bruining, et al.. (2007). Two-Year Serial Coronary Angiographic and Intravascular Ultrasound Analysis of In-Stent Angiographic Late Lumen Loss and Ultrasonic Neointimal Volume from the TAXUS II Trial. The American Journal of Cardiology. 99(5). 607–615. 35 indexed citations

11.

Teupser, Daniel, Joerg Koglin, Wolfgang Wilfert, et al.. (2007). CD36 mRNA EXPRESSION IS INCREASED IN CD14⁺ MONOCYTES OF PATIENTS WITH CORONARY HEART DISEASE. Clinical and Experimental Pharmacology and Physiology. 35(5-6). 552–556. 21 indexed citations

12.

Escolar, Esteban, Gary S. Mintz, Jeffrey J. Popma, et al.. (2007). Meta-Analysis of Angiographic Versus Intravascular Ultrasound Parameters of Drug-Eluting Stent Efficacy (from TAXUS IV, V, and VI). The American Journal of Cardiology. 100(4). 621–626. 14 indexed citations

13.

Dawkins, Keith D., Gregg W. Stone, Antonio Colombo, et al.. (2006). Integrated analysis of medically treated diabetic patients in the TAXUS(R) program: benefits across stent platforms, paclitaxel release formulations, and diabetic treatments.. PubMed. 2(1). 61–8. 14 indexed citations

14.

Ong, Andrew T.L., Patrick W. Serruys, Marie-Claude Morice, et al.. (2006). The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: Design, rationale, and run-in phase. American Heart Journal. 151(6). 1194–1204. 225 indexed citations

15.

Weissman, Neil J., Joerg Koglin, David A. Cox, et al.. (2005). Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation. Journal of the American College of Cardiology. 45(8). 1201–1205. 72 indexed citations

16.

Ellis, Stephen G., Jeffrey J. Popma, John M. Lasala, et al.. (2005). Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation. Journal of the American College of Cardiology. 45(8). 1193–1200. 122 indexed citations

17.

Methe, Heiko, Ulrich Welsch, Fritz Krombach, et al.. (2005). Peripheral Expansion of Circulating T-Helper 1 Cells Predicts Coronary Endothelial Dysfunction After Cardiac Transplantation. The Journal of Heart and Lung Transplantation. 24(7). 833–840. 13 indexed citations

18.

Stone, Gregg W., Stephen G. Ellis, Louis Cannon, et al.. (2005). Comparison of a Polymer-Based Paclitaxel-Eluting Stent With a Bare Metal Stent in Patients With Complex Coronary Artery Disease. JAMA. 294(10). 1215–1215. 612 indexed citations breakdown →

19.

Methe, Heiko, et al.. (2004). Evidence for a Role of Toll-Like Receptor 4 in Development of Chronic Allograft Rejection after Cardiac Transplantation. Transplantation. 78(9). 1324–1331. 71 indexed citations

20.

Schenk, Sören, Hermann Reichenspurner, Dieter H. Boehm, et al.. (2002). Myosplint implant and shape-change procedure: intra- and peri-operative safety and feasibility. The Journal of Heart and Lung Transplantation. 21(6). 680–686. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact